🇺🇸 FDA
Patent

US 10981944

Modulators of 5′-nucleotidase, ecto and the use thereof

granted A61KA61K31/70A61K31/7052

Quick answer

US patent 10981944 (Modulators of 5′-nucleotidase, ecto and the use thereof) held by Arcus Biosciences, Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/70, A61K31/7052, A61K31/706, A61K31/7064